InMode Ltd. remains a Strong Buy at current levels, supported by a robust balance sheet, proprietary technology, and international growth. Green shoots include a 2.7% rise in consumables/servicing ...

InMode (NASDAQ:INMD) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

We are writing to make you aware that we have expressed interest to InMode’s leadership in pursuing an acquisition by Steel Partners of 51% of the Company’s outstanding shares for $18.00 per share, ...

InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since ...

Jan 28 (Reuters) - Investment firm Steel Partners said on Wednesday it had offered $18 per share to acquire a 51% stake in InMode (INMD.O), opens new tab, ‌sending the Israel-based medical technology ...

InMode Ltd. (NASDAQ:INMD) reported fourth-quarter earnings and revenue on Tuesday that came in ahead of expectations, but its weaker-than-anticipated guidance for 2026 weighed on investor sentiment.

YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement ...

The committee, formed by InMode's board, evaluated multiple proposals for a potential transaction with help from outside financial and legal advisers. After reviewing the final bids, it concluded that ...

InMode (INMD) rose 14% after a report that a foreign investment fund is in talks to purchase the Israeli medical aesthetics company in a deal that values the company at about $1.1 billion. InMode ...

YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...